Wed09302020

Robins Global News & Noticias



Presidential Debates | COVID-19 Map Tracker | COVID-19 News Features


  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Metacrine Announces Pricing of Initial Public Offering


SAN DIEGO, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced the pricing of its initial public offering of 6,540,000 shares of its common stock at a public offering price of $13.00 per share. The gross proceeds to Metacrine from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Metacrine, are expected to be approximately $85.0 million. In addition, Metacrine has granted the underwriters a 30-day option to purchase up to 981,000 additional shares of its common stock at the initial public offering price, less the underwriting discounts and commissions. All of the shares are being offered by Metacrine.

Metacrine has been approved for listing on the Nasdaq Global Market and is expected to begin trading on Wednesday, September 16, 2020 under the ticker symbol “MTCR.” The offering is expected to close on Friday, September 18, 2020, subject to customary closing conditions. 

Jefferies, Evercore ISI and RBC Capital Markets are acting as joint book-running managers for the offering. Canaccord Genuity is acting as lead manager for the offering.  

A registration statement relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission on September 15, 2020. The offering is made only by means of a prospectus, copies of which may be obtained, when available, from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.; Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 36th Floor, New York, NY 10055, by telephone at (888) 474-0200, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.; or RBC Capital Markets, LLC, Attention: Equity Syndicate, 200 Vesey Street, 8th Floor, New York, NY 10281, by telephone at (877) 822-4089, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it..

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Metacrine
Metacrine is a clinical-stage biopharmaceutical company building a differentiated pipeline of therapies to treat liver and gastrointestinal (GI) diseases. The company’s most advanced programs, MET409 and MET642, target the farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. Both MET409 and MET642 are currently being investigated in clinical trials as potential new treatments for non-alcoholic steatohepatitis (NASH).

Contact:
Chelcie Lister
THRUST Strategic Communications
910-777-3049
This email address is being protected from spambots. You need JavaScript enabled to view it.




Posted: 2020-09-16 01:52:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.





Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Metacrine Announces Pricing of Initial Public Offering | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

Yalla Group Limited Announces Pricing of Initial Public Offering

Wed, 30 Sep 2020 08:44:00 GMT

Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the leading voice-centric social networking and entertainment platform in the Middle East and North Africa (MENA), today announced the ...

Chindata Group Announces Pricing of Initial Public Offering

Wed, 30 Sep 2020 07:28:00 GMT

PRNewswire/ -- Chindata Group Holdings Limited ("Chindata Group"), a leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets, today announced the pricing of ...

Qell Acquisition Corp. Announces Pricing of Upsized $330 Million Initial Public Offering

Wed, 30 Sep 2020 04:01:00 GMT

Qell Acquisition Corp. (Nasdaq: QELLU, the "Company") announced today that it priced its initial public offering of 33,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasd ...

Climate Change Crisis Real Impact I Acquisition Corporation Announces Pricing of $200 Million Initial Public Offering

Tue, 29 Sep 2020 16:43:00 GMT

Climate Change Crisis Real Impact I Acquisition Corporation (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are ...

FG New America Acquisition Corp. Announces Pricing of $225 Million Initial Public Offering

Tue, 29 Sep 2020 16:01:00 GMT

PRNewswire/ -- FG New America Acquisition Corp (the "Company") today announced the pricing of its initial public offering of 22,500,000 units at a price ...

Related News Story Videos From Youtube






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.